| Application no. and date | 11772735.4 (espacenet) (Federated) (European Patent Register), 20110421 | | Patent/reg. no. and date | DK/EP 2560658, 20170222 | | Publication date | 20130227 | | Priority no. and date | US 326406 P, 20100421 | | EP pub. no. and date |
EP 2560658 20130227 | | Effective date | | | Applicant/owner | VentiRx Pharmaceuticals, Inc., 1191 Second Avenue, Suite 1105
Seattle, WA 98101, US | | Applicant ref. no. | V1704-028-DK | | Inventor | HERSHBERG, Robert, 900 Lenora Street, 1103
Seattle, WA 98121, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/55 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , C07K 16/28 (2006.01) , C07K 16/32 (2006.01) | | Title | FORSTÆRKNING AF ANTISTOFAFHÆNGIG CELLULÆR CYTOTOKSICITET | | Int. application no. | US2011033500 | | Int. publication no. | WO2011133819 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
